Legalize59765 laws
59765 laws
- § 387a. FDA authority over tobacco products
- § 387a–1. Final rule
- § 387b. Adulterated tobacco products
- § 387c. Misbranded tobacco products
- § 387d. Submission of health information to the Secretary
- § 387e. Annual registration
- § 387f. General provisions respecting control of tobacco products
- §§ 1261 to 1266. Omitted
- § 387f–1. Enforcement action plan for advertising and promotion restrictions
- § 387g. Tobacco product standards
- § 387h. Notification and other remedies
- § 387i. Records and reports on tobacco products
- § 387j. Application for review of certain tobacco products
- § 387k. Modified risk tobacco products
- § 387l. Judicial review
- § 387m. Equal treatment of retail outlets
- § 387n. Jurisdiction of and coordination with the Federal Trade Commission
- § 387o. Regulation requirement
- § 387p. Preservation of State and local authority
- § 387q. Tobacco Products Scientific Advisory Committee
- § 387r. Drug products used to treat tobacco dependence
- § 387s. User fees
- § 387t. Labeling, recordkeeping, records inspection
- § 387u. Studies of progress and effectiveness
- § 387v. Reporting on tobacco regulation activities
- § 391. Separability clause
- § 392. Exemption of meats and meat food products
- § 393. Food and Drug Administration
- § 393a. Office of Pediatric Therapeutics
- § 394. Scientific review groups
- § 395. Loan repayment program
- § 396. Practice of medicine
- § 397. Contracts for expert review
- § 398. Notices to States regarding imported food
- § 399. Grants to enhance food safety
- § 399a. Office of the Chief Scientist
- § 399b. Office of Women’s Health
- § 399c. Improving the training of State, local, territorial, and tribal food safety officials
- § 399d. Employee protections
- § 399e. Nanotechnology
- § 399f. Ensuring adequate information regarding pharmaceuticals for all populations, particularly underrepresented subpopulations, including racial subgroups
- § 399g. Food and Drug Administration Intercenter Institutes
- § 399h. National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing
- § 399i. Food and Drug Administration Working Capital Fund
- §§ 41 to 50. Repealed. [Pub. L. 104–128, § 2](/us/pl/104/128/s2), Apr. 9, 1996, [110 Stat. 1198](/us/stat/110/1198)
- § 451. Congressional statement of findings
- § 452. Congressional declaration of policy
- § 453. Definitions
- § 454. Federal and State cooperation in development and administration of State poultry product inspection programs
- § 455. Inspection in official establishments